Extreme Option Profits Chart of Day…Altimmune Inc. (ALT)

Keep an eye on Altimmune Inc. (ALT).

The stock is pushing higher thanks to more positive data on its COVID candidate.

The company just published positive pre-clinical data for its new single-dose, intranasal COVID-19 vaccine candidate AdCOVID, adding the candidate “stimulates three key immune components: serum neutralizing antibody, T cell responses, and mucosal immunity in the respiratory tract.”

“AdCOVID is designed to offer significant advantages over other COVID-19 vaccine approaches, including intranasal administration, single-dose effectiveness, broad activation of the immune response, and the ability to ship and store the vaccine conveniently and inexpensively,” according to the company.

The opportunities we find quite often inside Extreme Option Profits.

EARN 58% & MORE Per Trade On Average
& Risk 91% LESS Doing It!

Potentially EARN 6,438% More Per Year By Defying All Of the Regular, Ordinary, Common, Boundaries & Restrictions On  Trading & Investing (like our model portfolio)…

…With Speed, Convenience, & FREEDOM!

…& Risk As Little As $300 & NEVER Own A Single Stock or ETF!

Go Here to Learn More...